Healthcare

Telix Pharmaceuticals Limited (ASX:TLX) has secured positive rating from multiple brokers, citing valuation upside based on their respective target prices. Recently, the company reported FY25revenueof USD 803.8 million, a 56% increase year-on-year, while outlining expanded investment across its therapeutic and precision medicine pipeline.

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH) has upgraded its revenue and earnings guidance for the financial year ending 31 March 2026, citing favourable exchange rates and continued growth across its hospital product portfolio. Shares in the company rose 5.09% to AUD 33.27 during …

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.

The Australian healthcare sector is experiencing notable investor enthusiasm as three ASX-listed companies – Sonic Healthcare (ASX:SHL), Cyclopharm (ASX:CYC), and Alcidion Group (ASX:ALC) – reported positive operational and commercial developments. Impressive half-year financial performance, strategic US expansion, and regulatory approvals for AI healthcare tools …

Sonic Healthcare Limited (ASX:SHL) advanced 12.99% to AUD 24.00 on 19 February 2026 after reporting its financial results for the half-year ended 31 December 2025, with revenue growth, higher earnings per share and confirmation of full-yearEBITDAguidance. The market reaction followed the earnings update, margin …

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.